Challenges in treating refractory epilepsy and why new antiepileptic drugs are required

Challenges in treating refractory epilepsy and why new antiepileptic drugs are required

Neurology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 21 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 10 Sep 2021 

Overview

NEW!

Epilepsy is a chronic neurological condition, affecting approximately 50 million individuals of all ages globally. Most patients with epilepsy can achieve good seizure control with appropriate antiepileptic drug (AED) therapy, and the choice of initial AED is a significant predictor of long-term response in patients with newly diagnosed epilepsy. Nevertheless, up to 40% of patients are still suffering from seizures despite being given adequate doses of appropriately selected AEDs. This online module discusses challenges in treating medically resistant epilepsy while simultaneously highlighting the need for new AEDs to address the gaps in managing resistant epilepsy

CPD Reviewer:

Prof Dato' Dr Raymond Azman
Senior Consultant Neurologist
UKM Medical Centre,
Chairman, Epilepsy Council of Malaysia

NOTE :
Please watch the video before attempting the assessment questions.

Terms & Conditions: 
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points. 

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by:

Eisai_logo.jpg